We identified a range of potential biomarkers, including genes such as Ccl8, Pdcd1, Gzmk, and metabolites like kynurenine, adipoyl-carnitine, L-glutamine, which can be used for monitoring influenza risk. This evidence concerns the gene GZMK and influenza.